Trouble is the low expectation of shareholders, management need to be held responsible and not let off the hook.
The share price now back to the level it was before the data from the phase 1 trial.
MT was handed this on a silver plate and has sat back and watch the sp fall.
Big talk around big pharmas paying interest do
esn't cut the mustard.
Maybe why the big pharmas don't sign up is due to MT not being able to sell the story, or do they know something we don't.
Adivisors coming out of his ears, Healey so called experts and still same crap we got from the old board.
Stand up MT and tell shareholders what's really going on
Ann: Neurizon updates on NUZ-001 IND Application, page-419
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $86.15M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.5¢ | 16.5¢ | $91.76K | 527.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 80407 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 31 | 1 |
View Market Depth
| Last trade - 15.34pm 20/06/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |